Pacira BioSciences (PCRX) Change in Inventory (2010 - 2026)

Pacira BioSciences' Change in Inventory history runs 17 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 129.4% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at $16.6 million (down 55.09% YoY), while the FY2025 annual figure was $27.6 million, up 31.72% from the prior year.
• Change in Inventory was -$2.5 million for Q1 2026 at Pacira BioSciences, up from -$4.8 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $14.4 million in Q2 2025 to a low of -$7.6 million in Q1 2024.
• Historically, Change in Inventory has averaged $3.0 million across 5 years, with a median of $4.4 million in 2023.
• Biggest YoY gain for Change in Inventory was 11988.37% in 2022; the steepest drop was 567.17% in 2022.
• A 5-year view of Change in Inventory shows it stood at -$735000.0 in 2022, then soared by 1165.71% to $7.8 million in 2023, then surged by 71.29% to $13.4 million in 2024, then sank by 135.9% to -$4.8 million in 2025, then soared by 48.29% to -$2.5 million in 2026.
• The last three Change in Inventory figures came in at -$2.5 million (Q1 2026), -$4.8 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.